Liang Janet sold $194K of OSCR
Liang Janet (President, Oscar Insurance) sold 8,940 shares of Oscar Health, Inc. (OSCR) at $21.74 ($0.19M total) on 2026-06-02 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure provides a datapoint on insider behavior but does not, by itself, change Oscar Health’s fundamentals or announce a new operational/regulatory event.
Market read
Traders may note the insider sale for sentiment, but the 10b5-1 framing suggests limited informational content.
What to watch
The filing does not indicate whether additional insider buys/sales occurred around the same period or whether the plan size/pace is consistent with prior months.
Background
SEC Form 4 reports insider transactions; this one is an officer/direct sale executed under a pre-arranged Rule 10b5-1 plan.
Ticker impact
Oscar Health disclosed an officer open-market sale of 8,940 shares at ~$21.74 under a pre-arranged 10b5-1 plan.
Likely limited/short-lived impact; any move would be more sentiment-driven than fundamental.
The filing is a routine Form 4 transaction and explicitly tied to a pre-arranged 10b5-1 plan, reducing the likelihood of new, company-specific information.
Market effects
Minimal; this is company-specific insider activity with no stated sector-wide catalyst.
None indicated.
None indicated.
Counterpoint
Because the sale is pre-arranged under 10b5-1, it may reflect scheduled liquidity needs rather than bearish expectations; price reaction may be overstated.
Key entities
- issuerOscar Health, Inc.
Subject of the Form 4 insider transaction; officer (President, Oscar Insurance) sold shares under a 10b5-1 plan.
- insiderLiang Janet
President, Oscar Insurance; executed an open-market sale of 8,940 OSCR shares at $21.7400 on 2026-06-02.
